Clinical Trial Update: LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for carbo with nab-paclitaxel in advanced non-small cell lung cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• carbo (carboplatin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-11